The Potential Risks of Combining Vascepa with Blood Thinners: What You Need to Know As the medical community continues to… https://www.Drugchatter.com/chat/17808/are-there-any-potential-side-effects-of-combining-vascepa-with-blood-thinners/
Pharma doesn’t just “own” a drug patent—it often extends control over time.
That’s the core tension behind the industry’s playbook for maximizing value from patent term extensions and secondary patents. In a world where blockbuster revenue is measured …
Your pharmaceutical portfolio may have a time bomb in it—and patent expiration data is the fuse.
If you’re a business leader in pharma, you already know the headline risk: patents expire, generics arrive, margins compress, and growth plans get rewritte…
The Hidden Dangers of Combining Lipitor with Salt Substitutes As we age, our bodies undergo a multitude of changes that… https://www.Drugchatter.com/chat/38920/are-there-any-dangers-in-using-lipitor-alongside-salt-substitutes/
DrugChatter: Are there any dangers in using lipitor alongside salt substitutes? Read Post »
Big Pharma loves a good wall.
Not the kind you can scale with grit and a ladder—but the kind built from patents, procedural delays, and “trust us” narratives. In the pharmaceutical world, IP strategy can feel like a fortress: opaque, expensive to chall…
Crack the Patent Wall: How Hard Data Beats Big Pharma’s IP Strategy Every Time Read Post »
Brands Don’t Launch “Competition” by Accident—They Do It to Control the Next Phase of the Market
There’s a quiet strategy playing out across pharma that most investors only notice after the damage is done: the authorized generic.
On the surface, it loo…
Dairy-Free Alternatives to Lipitor: Exploring Options for Statin-Free Heart Health As the world becomes increasingly aware… https://www.Drugchatter.com/chat/1561/are-there-any-dairy-free-alternatives-to-lipitor/
DrugChatter: Are there any dairy free alternatives to lipitor? Read Post »
Pick the Right FDA Pathway—and You Own the Market. Pick the Wrong One—and You’re Funding Your Competitor.
In pharma, the most expensive mistake isn’t a failed clinical trial. It’s a strategic misstep that happens after the science is done—when you choo…
Blockbuster drugs don’t die when patents expire. They evolve.
The patent clock running out is the moment everyone watches—because it’s when generic competition can finally enter. But in practice, “expiration” is rarely the end of the story. It’s the …
Five Plays That Keep Your Blockbuster Drug Alive After the Patent Clock Runs Out Read Post »
The Wholesale Price of Eliquis in the USA: A Comprehensive Guide As a medication used to prevent stroke and blood clots… https://www.Drugchatter.com/chat/33959/what-is-the-wholesale-price-of-eliquis-in-the-usa/
DrugChatter: What is the wholesale price of eliquis in the usa? Read Post »
Get new actionable insights and updates from BiotechBlog
